NCT01494545

Brief Summary

The purpose of this study was to evaluate the performance of DAILIES® TOTAL1™ in first time contact lens wearers.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2011

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 19, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

June 25, 2013

Completed
Last Updated

July 19, 2013

Status Verified

July 1, 2013

Enrollment Period

4 months

First QC Date

December 15, 2011

Results QC Date

May 1, 2013

Last Update Submit

July 12, 2013

Conditions

Keywords

DAILIES TOTAL1Alconcontact lens

Outcome Measures

Primary Outcomes (21)

  • Initial Comfort

    Initial comfort was rated by the participant and recorded on a questionnaire at time of lens dispense. Initial comfort was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 1

  • Comfort at Insertion by Visit

    Comfort at insertion was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Comfort at insertion was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Comfort During the Day by Visit

    Comfort during the day was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Comfort during the day was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Comfort at End of Day by Visit

    Comfort at end of day was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Comfort at end of day was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Overall Comfort by Visit

    Overall comfort was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Overall comfort was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Initial Quality of Vision

    Initial quality of vision was rated by the participant and recorded on a questionnaire at time of lens dispense. Initial quality of vision was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 1

  • Quality of Vision at Insertion by Visit

    Quality of vision at insertion was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Quality of vision at insertion was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Quality of Vision During the Day by Visit

    Quality of vision during the day was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Quality of vision during the day was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Quality of Vision at End of Day by Visit

    Quality of vision at end of day was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Quality of vision at end of day was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Overall Quality of Vision by Visit

    Overall quality of vision was rated by the participant and recorded on a questionnaire as a single, retrospective evaluation of the previous week of lens wear. Overall quality of vision was rated on a 10-point scale (1=poor to 10=excellent) as a single assessment for both eyes.

    Day 7, Day 14

  • Average Comfortable Daily Wear Time by Visit

    Average comfortable daily wear time was reported by the participant as a single, retrospective evaluation of the previous week of wear.

    Day 7, Day 14

  • Likert Statement: These Contact Lenses Were so Comfortable That I Don't Feel Anything.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 2=Strongly Agree; 1=Agree; -1=Disagree; -2=Strongly Disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: These Contact Lenses Were so Comfortable That I Barely Felt Anything.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 2=Strongly Agree; 1=Agree; -1=Disagree; -2=Strongly Disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: These Contact Lenses Felt so Comfortable That I Forgot I Was Wearing Them.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 2=Strongly Agree; 1=Agree; -1=Disagree; -2=Strongly Disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: These Contact Lenses Are Perfect for When I Choose Not to Wear my Eye Glasses.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 2=Strongly Agree; 1=Agree; -1=Disagree; -2=Strongly Disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: I Liked These Contact Lenses so Much That I Will Recommend Them to my Friends.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 22=Strongly Agree; 1=Agree; -1=Disagree; -2=Strongly Disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: Overall, my Vision is Better With These Contact Lenses Compared to my Eye Glasses.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 2=Strongly Agree; 1=Agree; -1=Disagree; -2=Strongly Disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: At the End of the Day my Vision is Better With These Contacts Lenses Compared to my Eye Glasses.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 2=strongly agree; 1=agree; -1=disagree; -2=strongly disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: My Peripheral Vision is Better With These Contact Lenses Than With my Eye Glasses.

    The participant indicated agreement/disagreement with the statement by using a 4-point scale: 2=Strongly Agree; 1=Agree; -1=Disagree; -2=Strongly Disagree. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: Compared to my Eye Glasses, my Vision With These Contact Lenses is:

    The participant indicated overall satisfaction/dissatisfaction with the contact lenses using a 5-point scale: 2=Much Better; 1=A Little Better; 0=Same; -1=A Little Worse; -2=Much Worse. A single assessment was made for both eyes.

    Day 14

  • Likert Statement: I am Interested in Purchasing These Contact Lenses.

    The participant indicated purchase intent using a 4-point scale: 2=Very Interested; 1=Interested; -1=Not Interested; -2=Very Disinterested. A single assessment was made for both eyes.

    Day 14

Secondary Outcomes (7)

  • Lens Surface Characteristics: Dry Areas/Non-wetting

    Day 1

  • Lens Surface Characteristics: Dry Areas/Non-Wetting

    Day 7

  • Lens Surface Characteristics: Dry Areas/Non-Wetting

    Day 14

  • Duration of Overall Training Time

    Day 1

  • Investigator's Satisfaction With Lens Fit by Visit

    Day 1, Day 7, Day 14

  • +2 more secondary outcomes

Study Arms (1)

Delefilcon A

EXPERIMENTAL

Delefilcon A contact lenses worn in both eyes on a daily wear, daily disposable basis for two weeks. A new pair was inserted each day.

Device: Delefilcon A contact lens

Interventions

Silicone hydrogel contact lens CE-marked for single use, daily disposable wear

Also known as: DAILIES® TOTAL1™
Delefilcon A

Eligibility Criteria

Age18 Years - 44 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Sign Informed Consent.
  • No previous contact lens experience or attempt to try contact lenses (neophyte).
  • Willing to wear study lenses for at least 8 hours a day for at least 5 days a week.
  • Use spectacle lenses for vision correction.

You may not qualify if:

  • years or older.
  • Prior wear experience with rigid or soft contact lenses.
  • Systemic or ocular disease or disorder that would negatively affect the conduct or outcome of the study.
  • History of ocular surgery/trauma within the last six months.
  • Pregnant or nursing women.
  • Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Jami Kern, PhD
Organization
Alcon Research, Ltd

Study Officials

  • Jami Kern, PhD

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2011

First Posted

December 19, 2011

Study Start

December 1, 2011

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

July 19, 2013

Results First Posted

June 25, 2013

Record last verified: 2013-07